Practice Economics

Medicare Trust Fund projected to run dry in 2028


 

References

The Medicare Trust Fund is projected to become insolvent in 2028, 2 years earlier than projected this time last year.

The change is based on two key factors: an expected reduction in payroll taxes and a slowdown in declining rate of inpatient utilization, Andy Slavitt, acting administrator of the Centers for Medicare & Medicaid Services said at a June 22 press conference to review the annual Medicare Trustees report.

©MADDRAT/thinkstockphotos.com

“The good news is inpatient utilization is still declining, it’s just declining at a slightly lower rate,” Mr. Slavitt said.

He also highlighted the continuing rising cost of prescription medications, which he called “a major driver” in Medicare spending growth.

“For the second year in a row, we saw spending growth for prescription drugs dramatically outpace cost growth for other Medicare services,” Mr. Slavitt said. “Through 2025, Medicare Part D expenditures per enrollee are estimated to increase nearly 50% higher than the estimated increase in GDP per capita and higher than the combined per enrollee growth rate of Medicare Part A and Medicare Part B combined.”

Overall, total Medicare expenditures “are slightly lower than estimated last year,” Mr. Slavitt said, adding that over the next decade, “Medicare per-enrollee spending is projected to continue to grow slower than historical rates, at 4.3%, lower than the growth in overall per capita national health expenditures.”

The growth rate is not projected to trigger the activation of the Independent Payment Advisory Board, according to the report.

In 2015, Medicare covered 55.3 million people, including 46.3 million aged 65 and older, and 9 million disabled individuals.

gtwachtman@frontlinemedcom.com

Recommended Reading

DACA: High Court ruling could squash dreams of becoming a doctor
MDedge Hematology and Oncology
Mastering MACRA: How to thrive under new payment models
MDedge Hematology and Oncology
Law & Medicine: Locality rule
MDedge Hematology and Oncology
Doctors ask Congress to stop Part B drug payment test
MDedge Hematology and Oncology
Oncologists/hematologists’ hospital revenue down slightly since 2012
MDedge Hematology and Oncology
Judge says feds overstepped on ACA cost-sharing subsidies
MDedge Hematology and Oncology
Cancer drugs most affordable in Australia, least in India and China
MDedge Hematology and Oncology
Prepare early for peer review hearings to avoid negative outcomes
MDedge Hematology and Oncology
8 steps to avoid legal risks from your practice website
MDedge Hematology and Oncology
Dos and don’ts of dealing with disruptive behavior
MDedge Hematology and Oncology